Minolast-FXA Tablet SR is a once-daily, delayed-release formulation of montelukast, fexofenadine, and acebrophylline, designed to provide comprehensive relief from respiratory and allergic symptoms. The combination of montelukast, a leukotriene receptor antagonist, and fexofenadine, a non-sedating antihistamine, addresses the root causes of allergic rhinitis and chronic asthma. Montelukast's action on leukotrienes helps to reduce bronchospasm and airway constriction, while fexofenadine's histamine-1 receptor blockade alleviates pruritus, sneezing, and runny nose. Acebrophylline, a phosphodiesterase inhibitor, enhances bronchodilation and improves respiratory function. In patients with moderate to severe allergic rhinitis and/or chronic asthma, Minolast-FXA Tablet SR provides long-lasting, 24-hour relief from nasal congestion, sneezing, runny nose, itchy eyes, and wheezing. This once-daily tablet is suitable for adults and children aged 12 years and above, offering a convenient and effective treatment option for those seeking comprehensive symptom management.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.